In this new era, we’re ready.
Together, let’s reimagine medicine to improve and extend people’s lives.
*Based on 2022 data except for employees which has been restated to exclude Sandoz
** Based on 2022 data, excluding Sandoz
*** Based on 2022 data, excluding Sandoz: 236 million patients reached with innovative medicines; 54 million patients reached through Novartis Global Health, which focuses on transforming health in low- and middle-income countries.